Explore the latest in prostate cancer, including recent screening guidelines and advances in management of localized and metastatic disease.
This systematic review and meta-analysis examines the risk of toxic effects associated with second-generation antiandrogens administered to men with prostate cancer in randomized clinical trials.
This cohort study develops and validates a nomogram of for prediction of freedom from biochemical failure after prostate-specific antigen membrane positron-emission tomography–based salvage radiotherapy for recurrent or persistent prostate cancer.
This systematic review and meta-analysis investigates the comparative effectiveness of triplet therapy vs androgen pathway inhibitors doublet therapy for patients with heterogeneous metastatic castration-sensitive prostate cancer.
This case series investigated the rate of prostate cancer diagnoses among transgender women treated in the Veterans Affairs health system.
This systematic review and meta-analysis systematically evaluates the current evidence regarding 5α-reductase inhibitor use and prostate cancer mortality.
This survey study examines the pattern of and factors associated with prostate cancer screening in US males aged 70 years or older.
This randomized clinical trial examines whether the addition of metastasis-directed therapy (MDT) to intermittent hormone therapy in men with oligometastatic prostate cancer improves progression-free survival.
This cross-sectional study of data from the Surveillance, Epidemiology and End Results database assesses temporal trends in the use of active surveillance and watchful waiting vs definitive treatment in men with low- and favorable intermediate–risk prostate cancer in the US between 2010 and 2018.
This retrospective cohort study compares 2 risk calculator systems that compute the probabilities of finding high-grade or any cancer on biopsy results in men undergoing a first prostate biopsy.
This randomized clinical trial compares data for patients who underwent ablation therapy to determine the effects of focal vs extended irreversible electroporation on early oncological control as indicated by presence on follow-up biopsy of clinically significant prostate cancer.
This randomized clinical trial examines whether a hyaluronic acid rectal spacer could improve rectal dosimetry and affect acute grade 2 or higher gastrointestinal toxic effects for hypofractionated radiation therapy.
This cohort study of men treated at US urology practices uses a national disease registry to analyze trends and variation in the use of active surveillance for the treatment of low-risk prostate cancer.
This randomized clinical trial assesses genitourinary toxic effects after magnetic resonance imaging (MRI)–guided vs computed tomography (CT)–guided stereotactic body radiotherapy for prostate cancer.
This meta-analysis examines disparities in the inclusion of racial and ethnic minority groups and older adults across prostate cancer clinical trials.
Customize your JAMA Network experience by selecting one or more topics from the list below.